Nilicon 1 gm/vial (IV Injection)
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Ethical drugs limited |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
Ceftriaxone is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic with potent bactericidal activity against a wide range of bacteria. It interferes with bacterial cell wall synthesis and has high stability in the presence of beta lactamases. It has a relatively long plasma elimination half-life of about 6 to 9 hours and is not metabolized in the body. It is highly protein bound and excreted primarily through urine and feces.
Dosage
- 1 to 2 gm by intravenous or intramuscular administration once a day (or in equally divided doses twice a day) for adults
- 50 to 75 mg/kg intravenous or intramuscular administration once a day (or in equally divided doses twice a day) for infants and children
- Duration of therapy: continue for more than 2 days after signs and symptoms of infection have disappeared
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections:
- For Intramuscular Injection: 250 mg or 500 mg Ceftriaxone should be dissolved in Lidocaine HCI 1% injection
- For Intravenous Injection: 250 mg or 500 mg Ceftriaxone should be dissolved in Water for injection
- The injection should be administered over 2-4 minutes, by Intramuscular or Intravenous injection or by tubing infusion over a period of 30 minutes at concentration between 10 mg/mL and 40 mg/mL
Interaction
No drug interactions have been reported
Contraindications
Ceftriaxone should not be given to patients with a history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea and vomiting
- Cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness
- Local phlebitis occurs rarely following intravenous administration
Pregnancy & Lactation
Safety in human pregnancy has not been established. It should not be used in pregnancy unless absolutely indicated. Caution should be exercised when administered to a lactating mother.
Precautions & Warnings
- Anaphylactic shock may occur
- Shadows suggesting sludge in the gallbladder have been detected in rare cases
- Blood picture should be checked at regular intervals during prolonged treatment
Use in Special Populations
Nilicon must not be given to neonates if premature and newborn (up to 28 days of age)
Overdose Effects
There is no specific antidote. Treatment of overdosage should be symptomatic
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Vial store in a cool, dry place (below 30°C), away from light & moisture. Keep out of the reach of children
Related Brands
- Nilicon 500 mg/vial (IV Injection) - ethical-drugs-limited
- Nilicon 250 mg/vial (IV Injection) - ethical-drugs-limited
- Nilicon 250 mg/vial (IM Injection) - ethical-drugs-limited
- Holicef 1 gm/vial (IM Injection) - concord-pharmaceuticals-ltd
- Holicef 1 gm/vial (IV Injection) - concord-pharmaceuticals-ltd